Insider trades
Yujiro S. Hata, Director of Enanta Pharmaceuticals ENTA, has filed 0 purchases and 14 sales on the open market. The latest trade was on 03/11.
Yujiro S. Hata
Director
- Company
- Enanta Pharmaceuticals ENTA
- First filing
- 23/02/28
- Trades
- 44 trades
- Buys / sales
- 0 / 14
- 12-month net buying
- No record
- Last trade
- 03/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
IDYA | Open-market sale10b5-1 plan | 24/05/14–24/05/16 | 24/05/16 | 175,000 sh7 trades | $42.27avg. | $7,397,014.85 | −20.5% |
IDYA | Open-market sale10b5-1 plan | 24/02/08–24/02/09 | 24/02/12 | 99,372 sh2 trades | $45.24avg. | $4,495,833.03 | −12.8% |
IDYA | Open-market sale10b5-1 plan | 24/02/01 | 24/02/05 | 628 sh2 trades | $45.00avg. | $28,260.04 | −0.1% |
IDYA | Open-market sale10b5-1 plan | 24/01/12–24/01/16 | 24/01/17 | 75,000 sh2 trades | $40.15avg. | $3,011,156.07 | −10.0% |
| Open-market sale10b5-1 plan | 23/12/15 | 23/12/19 | 75,000 sh | $35.03 | $2,627,250 | −10.0% |
